This site is intended for healthcare professionals

Targeted therapies in HER2 negative breast cancer

Read time: 5 mins
Last updated:23rd Aug 2019
Published:9th Aug 2019
Source: Medthority
In the third part of our four-part series detailing targeted breast cancer therapies, we focus on the HER2 negative subtype that is more difficult to treat than HER2 positive breast cancers.
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.